Oregano Oil for Health & Longevity - Quick Reference Sheet

Oregano Oil for Health & Longevity

Created on 08/22/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4.5 Audit

Oregano oil is a concentrated extract, not a spice. Human evidence is limited to short courses against documented gut infections, not a daily longevity tonic. Isolated main-compound capsules and water distillates are not the same as retail capsules. Harms are chemical burns from undiluted oil, gut burning, mint-family allergy, and avoidance in pregnancy. Many products lack the labeled main compound. (Full Review)

Protocol

Dose
200 mg 3× daily (600 mg/day)
Emulsified oil for 6 weeks, then stop
Timing
With meals, 2–3× daily
Human half-life undefined; split doses rather than one large amount
Setting
Documented gut pathogens
Unselected immune support has no trial dose
Time to effect
Selected intestinal protozoa
6 weeks
Stool clearance judged at 6 weeks
Uncomplicated bacterial infections in metabolic syndrome
10 days
Direction toward similar clearance versus antibiotics
Airway symptoms and lung function (isolated carvacrol)
1–2 months
Isolated carvacrol, not whole oregano oil

Benefits

Contraindications
  • Pregnancy, attempted conception, and breastfeeding
  • Known allergy to oregano, thyme, basil, sage, mint, lavender, or other Lamiaceae
  • Infants and young children (undiluted or high-carvacrol oil)
  • Active peptic ulcer, erosive esophagitis, or undiagnosed gastrointestinal bleeding
  • Elective surgery within 14 days
  • Unsupervised use of undiluted essential oil on skin, in the ear canal, or by mouth
Key Interactions
  • Anticoagulants and antiplatelets (warfarin, apixaban, clopidogrel, aspirin)
  • CYP2A6 substrates (nicotine replacement, letrozole, coumarin-type agents)
  • Insulin and sulfonylureas (glipizide, glyburide, glimepiride)
  • Other gut antimicrobials (berberine, allicin, olive-leaf oleuropein, rifaximin)
  • Nonsteroidal anti-inflammatory drugs (NSAIDs, such as ibuprofen, naproxen)
  • Iron supplements (separate by about 2 hours)
  • Lithium and diuretics (lithium, furosemide, hydrochlorothiazide)

Risk & Side Effects

  • High: Chemical irritation of skin and mucosa
  • Medium: Gastrointestinal burning, nausea, and bowel change; pregnancy and developmental concern
  • Low: Immediate allergy within the mint family; bleeding tendency; CYP2A6-pathway drug interaction; additive glucose lowering
  • Speculative: Long-term microbiome disruption; low-dose estrogenic or mutagenic laboratory signals

Monitoring

Marker Target Why
ALT / AST ALT often <25 U/L men, <19 U/L women Phenolic oils can irritate liver in high dose
Fasting glucose and HbA1c Glucose ~70–90 mg/dL; HbA1c ~4.8–5.3% Additive glucose lowering is plausible
hs-CRP <1.0 mg/L Inflammation marker used in carvacrol and hydrosol studies
ApoB or fasting lipid panel ApoB often <80 mg/dL if chasing lipid change Particle-number lipid marker used in the hydrosol lipid study
Stool ova/parasites or GI PCR Negative for the index organism Only human outcome tied to the oil itself
Lactulose breath test Fall in hydrogen/methane versus that person's baseline Used when small intestinal bacterial overgrowth is the question

Cadence: Baseline before a first pulse; labs when the course exceeds two weeks or glucose-lowering or anticoagulant drugs are in use; end of a 4–6 week pulse; as needed every 3–6 months if pulses repeat

Qualitative Assessment

  • Gut comfort: burning, reflux, cramping, or diarrhea during the pulse
  • Skin or lip irritation after topical or dropper use
  • Energy and training recovery if the pulse coincides with hard exercise
  • Bowel regularity after stopping
  • Easy bruising or gum bleeding if anticoagulants are in use